Avanc Pharmaceutical Co., Ltd (Avanc Pharma or the Company), a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, focuses on innovative drug R&D, production and distribution and has a long-term commitment to the nervous system, oncology, perioperative drugs and pediatric drugs. The Company has been granted 48 patents cumulatively, with another 30-plus products in the pipeline. Annual sales totals RMB 4 billion approximately. With sufficient capital at its disposal, Avanc Pharma has built world-class state-of-the-art pharmaceutical bases, and developed business across the entire pharmaceutical supply chain. A strategy defined by “endogenous growth, exogenous expansion and integrated development” is being implemented in an effort to become a domestic leader with global competitiveness.